rmi 12330a has been researched along with warfarin in 1 studies
Studies (rmi 12330a) | Trials (rmi 12330a) | Recent Studies (post-2010) (rmi 12330a) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
141 | 0 | 24 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | rmi 12330a (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, BK; Lee, CK; Lee, HJ; Lee, MK; Lim, SC; Yang, YJ | 1 |
1 other study(ies) available for rmi 12330a and warfarin
Article | Year |
---|---|
Effects of scoparone on dopamine release in PC12 cells.
Topics: Adenylyl Cyclase Inhibitors; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Coumarins; Cyclic AMP-Dependent Protein Kinases; Dopamine; Drug Evaluation, Preclinical; Imines; PC12 Cells; Phosphorylation; Potassium; Rats; Synapsins; Vasodilator Agents | 2010 |